Nexien BioPharma, Inc. (OTCMKTS:NXEN) Short Interest Update

Nexien BioPharma, Inc. (OTCMKTS:NXENGet Free Report) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totalling 28,900 shares, an increase of 28,800.0% from the March 31st total of 100 shares. Based on an average daily volume of 22,100 shares, the days-to-cover ratio is currently 1.3 days.

Nexien BioPharma Stock Down 28.0 %

NXEN stock traded down $0.01 during midday trading on Thursday, reaching $0.02. The company had a trading volume of 5,914 shares, compared to its average volume of 8,970. The company has a 50 day moving average of $0.02 and a two-hundred day moving average of $0.02. Nexien BioPharma has a 1 year low of $0.01 and a 1 year high of $0.10.

About Nexien BioPharma

(Get Free Report)

Nexien BioPharma, Inc focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc and changed its name to Nexien BioPharma, Inc in September 2018.

Further Reading

Receive News & Ratings for Nexien BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nexien BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.